Short answer
Tonix Pharmaceuticals Holding Corp. (TNXP) filed an 8-K current report with the SEC on September 22, 2026 reporting Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). TONMYA coverage added for approximately 21 million Medicare Part D beneficiaries through a pharmacy benefit manager.
Tonix Pharmaceuticals Holding Corp. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- TONMYA coverage added for approximately 21 million Medicare Part D beneficiaries through a pharmacy benefit manager
- Total government and commercial coverage now reaches approximately 166 million individuals
- Expanded reimbursement access could support TONMYA prescription adoption and commercialization
- Coverage agreement does not establish actual utilization, reimbursement revenue, or financial impact
Item EX-99.1 · Exhibit EX-99.1
- Second managed Medicare agreement effective immediately, adding approximately 21 million covered lives
- Medicare coverage reaches 32 million lives, or 58% of approximately 55 million U.S. Medicare lives
- Total commercial and government coverage reaches approximately 166 million lives, or 53% of U.S. lives
- Sales force expanded by approximately 50 representatives to 150, supporting TONMYA launch execution
- Broader reimbursement materially improves access potential, but revenue conversion depends on prescribing and payer utilization rules
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tonix Pharmaceuticals Holding Corp. 8-K filings
Get the next TNXP 8-K as it lands
Follow TNXP for push alerts, or ask the research agent what this filing means.